Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk promoting immunosuppression and immunotherapy resistance
RNA-seq (gene expression) · mouse · 54 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 54 samples: 13 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE196790_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA807308 and SRA study SRP359958. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 10 samples read as cases, 24 as controls.
How we read this: 13 replicated groups read from 54 sample titles; they account for 54 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM5901002 MCA38_CTRL_2 MCA38_CTRL
- GSM5901003 MCA38_CTRL_3 MCA38_CTRL
- GSM5901004 MCA38_CTRL_4 MCA38_CTRL
- GSM5901005 MCA38_CTRL_7 MCA38_CTRL
- GSM5901006 MCA38_CTLA_8 MCA38_CTLA
- GSM5901007 MCA38_CTLA_10 MCA38_CTLA
- GSM5901008 MCA38_CTLA_11 MCA38_CTLA
- GSM5901009 MCA38_CTLA_14 MCA38_CTLA
- GSM5901010 MCA38_PD1_16 MCA38_PD1
- GSM5901011 MCA38_PD1_17 MCA38_PD1
- GSM5901012 MCA38_PD1_18 MCA38_PD1
- GSM5901013 MCA38_PD1_19 MCA38_PD1
- GSM5901014 CT26_CTRL_24 CT26_CTRL
- GSM5901015 CT26_CTRL_27 CT26_CTRL
- GSM5901016 CT26_CTRL_28 CT26_CTRL
- GSM5901017 CT26_CTRL_29 CT26_CTRL
- GSM5901018 CT26_CTLA_32 CT26_CTLA
- GSM5901019 CT26_CTLA_34 CT26_CTLA
- GSM5901020 CT26_CTLA_35 CT26_CTLA
- GSM5901021 CT26_CTLA_36 CT26_CTLA
- GSM5901022 CT26_PD1_40 CT26_PD1
- GSM5901023 CT26_PD1_41 CT26_PD1
- GSM5901024 CT26_PD1_42 CT26_PD1
- GSM5901025 CT26_PD1_46 CT26_PD1
- GSM5901026 PancO2_CTRL_48 PancO2_CTRL
- GSM5901027 PancO2_CTRL_49 PancO2_CTRL
- GSM5901028 PancO2_CTRL_51 PancO2_CTRL
- GSM5901029 PancO2_CTRL_54 PancO2_CTRL
- GSM5901030 PancO2_CTLA_57 PancO2_CTLA
- GSM5901031 PancO2_CTLA_58 PancO2_CTLA
- GSM5901032 PancO2_CTLA_61 PancO2_CTLA
- GSM5901033 PancO2_CTLA_62 PancO2_CTLA
- GSM5901034 PancO2_PD1_64 PancO2_PD1
- GSM5901035 PancO2_PD1_68 PancO2_PD1
- GSM5901036 PancO2_PD1_70 PancO2_PD1
- GSM5901037 PancO2_PD1_71 PancO2_PD1
- GSM5901038 Panc02_sgNT_1 Panc02_sgNT
- GSM5901039 Panc02_sgNT_2 Panc02_sgNT
- GSM5901040 Panc02_sgNT_3 Panc02_sgNT
- GSM5901041 Panc02_sgNT_4 Panc02_sgNT
+ 14 more — browse all 54 samples with per-sample file links →
- GSE196788 Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk promoting immunosuppression and immunotherapy resistance [RNAseq_Panc02_sgNT_sgCda_tumor] 10 samples shares immunosuppression, immunotherapy, nucleotide, udp-driven, macrophage, cross-talk, resistance, promoting
- GSE302715 A tumor-associated macrophage-targeted immunocytokine leveraging T and NK cell synergy for potent cancer immunotherapy [scRNA-seq] 187 samples shares immunotherapy, macrophage
- GSE266110 7aaRGD - a novel SPP1/integrin signaling-blocking peptide reverses immunosuppression and improves anti-PD-1 immunotherapy outcomes in experimental gliomas 40 samples shares immunosuppression, immunotherapy
- GSE212259 Whole-course Taming of Tumor-associated Macrophages from Central to Peripheral using Engineered Outer Membrane Vesicle Nanohybrids for Improved Immunotherapy [part 1: RNA-seq] 36 samples shares immunotherapy, macrophage
- GSE281467 Coactivation of innate immune suppressive cells induces acquired resistance against cancer immunotherapy targeting the innate immune system [TIICs RNA-seq] 30 samples shares immunotherapy, resistance
- GSE267544 Classically activated macrophages undergo functionally significant nucleotide metabolism remodelling driven by nitric oxide 21 samples shares nucleotide, macrophage
- GSE281466 Coactivation of innate immune suppressive cells induces acquired resistance against cancer immunotherapy targeting the innate immune system [TME RNA-seq] 18 samples shares immunotherapy, resistance
- GSE275780 Dual Targeting of STING and PI3Kγ Eliminates Regulatory B Cells to Overcome STING Resistance for Pancreatic Cancer Immunotherapy [RNA-seq] 17 samples shares immunotherapy, resistance
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.